CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Esperion Therapeutics, Inc.  (ESPR)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Esperion Therapeutics's Quick Ratio

ESPR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

ESPR Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change 343.1 % 231.75 % 116.98 % 21.5 % 0.67 %
Y / Y Cash & cash equivalent Change -19.2 % -6.47 % -0.32 % 296.71 % 246.89 %
Quick Ratio MRQ 7.36 11.94 28.4 36.78 40.39
Overall Ranking # 299 # 235 # 235 # 0 # 0
Seq. Current Liabilities Change 49.21 % 104.46 % 30.42 % 11.36 % 11.72 %
Seq. Cash & cash equivalent Change -7.96 % -14.04 % 0.71 % 1.41 % 6.53 %



Quick Ratio second quarter 2017 Comment
Due to increase in Current Liabilities in the second quarter 2017, Quick Ratio fell to 7.36 below Esperion Therapeutics, Inc. average.

Within Major Pharmaceutical Preparations industry 72 other companies have achieved higher Quick Ratio than Esperion Therapeutics in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ESPR Segments?
See Quick Ratio ESPR on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 73
Healthcare Sector # 111
Overall Market # 299


Quick Ratio Statistics
High Average Low
61.81 24.78 2.5
(Dec 31 2015)   (Jun 30 2013)


You need to upgrade your Flash Player


Financial Statements
Esperion Therapeutics's Current Liabilities $ 23 Millions Visit ESPR's Balance sheet
Esperion Therapeutics's Cash & cash equivalent $ 167 Millions Visit ESPR's Balance sheet
Source of ESPR's Sales Visit ESPR's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Chimerix Inc  19.12 $ 148.528  Millions$ 7.768  Millions
Catalyst Pharmaceuticals, Inc.  19.09 $ 35.131  Millions$ 1.840  Millions
Tonix Pharmaceuticals Holding Corp.  18.78 $ 34.366  Millions$ 1.830  Millions
Paratek Pharmaceuticals, Inc.  18.75 $ 175.453  Millions$ 9.357  Millions
Flexion Therapeutics Inc  18.17 $ 359.859  Millions$ 19.805  Millions
Enanta Pharmaceuticals Inc  17.26 $ 192.015  Millions$ 11.122  Millions
Concert Pharmaceuticals, Inc.  17.02 $ 103.420  Millions$ 6.077  Millions
Aquinox Pharmaceuticals, Inc  16.15 $ 131.277  Millions$ 8.128  Millions
Dynavax Technologies Corp  16.14 $ 126.961  Millions$ 7.865  Millions
Medicinova Inc  16.12 $ 22.890  Millions$ 1.420  Millions
Spring Bank Pharmaceuticals, Inc.  15.91 $ 56.379  Millions$ 3.544  Millions
Otonomy, Inc.  15.83 $ 150.532  Millions$ 9.510  Millions
Aduro Biotech, Inc.  15.19 $ 377.243  Millions$ 24.831  Millions
Ovid Therapeutics Inc.  15.08 $ 106.546  Millions$ 7.065  Millions
Beigene, Ltd.  14.80 $ 407.430  Millions$ 27.525  Millions
Sophiris Bio Inc.  14.48 $ 24.029  Millions$ 1.660  Millions
Aeglea Biotherapeutics, Inc.  14.35 $ 63.393  Millions$ 4.418  Millions
Rexahn Pharmaceuticals, Inc.  13.98 $ 26.807  Millions$ 1.918  Millions
Nivalis Therapeutics, Inc.  13.83 $ 49.497  Millions$ 3.578  Millions
Abeona Therapeutics Inc.  13.82 $ 58.304  Millions$ 4.219  Millions
Xenon Pharmaceuticals Inc.  13.70 $ 51.696  Millions$ 3.774  Millions
Prophase Labs, Inc.  13.53 $ 37.280  Millions$ 2.756  Millions
Global Blood Therapeutics, Inc.  13.40 $ 229.816  Millions$ 17.148  Millions
Aimmune Therapeutics, Inc.  13.16 $ 237.325  Millions$ 18.040  Millions
Blueprint Medicines Corp  12.76 $ 421.014  Millions$ 32.992  Millions
Aldeyra Therapeutics, Inc.  12.23 $ 25.821  Millions$ 2.112  Millions
Corium International, Inc.  11.93 $ 66.563  Millions$ 5.579  Millions
Cempra, Inc.  11.83 $ 187.005  Millions$ 15.813  Millions
Adamas Pharmaceuticals Inc  11.62 $ 128.343  Millions$ 11.049  Millions
Kura Oncology, Inc.  11.38 $ 53.244  Millions$ 4.679  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
ALDA's Profile
Stock Price
ALDA's Financials
ALDA's Expectations
Business Description
Fundamentals
Charts & Quotes
ALDA's News
Suppliers
ALDA's Competitors
Customers & Markets
Economic Indicators
ALDA's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com